PAIN THERAPEUTICS INC's ticker is PTIE and the CUSIP is 69562K100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $183,000 | +57.8% | 205,197 | +0.5% | 0.00% | – |
| Q4 2016 | $116,000 | -42.9% | 204,153 | +0.3% | 0.00% | – |
| Q3 2016 | $203,000 | -54.4% | 203,457 | +0.1% | 0.00% | – |
| Q2 2016 | $445,000 | -1.8% | 203,283 | 0.0% | 0.00% | – |
| Q1 2016 | $453,000 | +27.2% | 203,283 | -0.1% | 0.00% | – |
| Q4 2015 | $356,000 | -4.0% | 203,457 | +0.2% | 0.00% | – |
| Q3 2015 | $371,000 | +6.0% | 203,109 | +0.2% | 0.00% | – |
| Q2 2015 | $350,000 | -17.1% | 202,761 | -9.3% | 0.00% | – |
| Q1 2015 | $422,000 | -4.7% | 223,619 | +2.2% | 0.00% | – |
| Q4 2014 | $443,000 | -48.1% | 218,700 | +0.2% | 0.00% | -100.0% |
| Q3 2014 | $853,000 | -26.0% | 218,265 | +8.9% | 0.00% | 0.0% |
| Q2 2014 | $1,152,000 | +20.9% | 200,460 | +15.6% | 0.00% | 0.0% |
| Q1 2014 | $953,000 | +16.8% | 173,400 | +3.2% | 0.00% | 0.0% |
| Q4 2013 | $816,000 | +78.9% | 168,087 | +0.2% | 0.00% | – |
| Q3 2013 | $456,000 | +50.5% | 167,797 | +22.3% | 0.00% | – |
| Q2 2013 | $303,000 | – | 137,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,797,689 | $13,597,000 | 9.60% |
| SOPHROSYNE CAPITAL LLC | 1,265,020 | $6,147,000 | 5.38% |
| Madison Street Partners, LLC | 976,653 | $4,747,000 | 4.46% |
| INTREPID CAPITAL MANAGEMENT INC /DE/ | 460,000 | $2,236,000 | 2.28% |
| Broadfin Capital, LLC | 1,230,000 | $5,978,000 | 0.79% |
| 683 Capital Management, LLC | 427,071 | $2,076,000 | 0.59% |
| AVALON CAPITAL MANAGEMENT | 138,520 | $673,000 | 0.57% |
| Cheyne Capital Management (UK) LLP | 92,700 | $451,000 | 0.49% |
| Visium Asset Management, LP | 4,350,000 | $21,141,000 | 0.42% |
| Gruss Capital Management LP | 789,811 | $3,838,000 | 0.29% |